Adetunji T. Toriola, MD, PhD
Professor of Surgery
Medical School: MD, Obafemi Awolowo University, Ile-Ife, Nigeria, 1998
DA (Diploma in Anesthesia), West African College of Surgeons, 2004
MPH (Master of Science in Public Health), University of Kuopio, Kuopio, Finland, 2007
PhD (Epidemiology), University of Tampere, Tampere, Finland, 2011
Post Doctoral Education
Postdoctoral Fellowship: German Cancer Research Center (DKFZ), Heidelberg, Germany, 2011-2012
Dr. Toriola’s research focuses on characterizing the molecular basis, and determinants of mammographic breast density and breast cancer in order to identify those that can be targeted in breast cancer prevention, especially in premenopausal women. He is the Principal Investigator on 2 R01s (R37CA23560,R01CA246592) in this research area. One of these is a phase II clinical trial investigating the effect of RANKL inhibition on mammographic breast density and breast tissue/blood markers in premenopausal women with dense breasts (R37CA235602: https://clinicaltrials.gov/ct2/show/NCT04067726). The second study uses state of the art metabolomics platforms to interrogate the metabolite profiles of mammographic breast density in premenopausal women (R01CA246592).
In addition, he performs molecular epidemiologic studies on colorectal and pancreatic cancers, evaluating the utility of biomarkers to investigate the associations of energetics, and inflammation with risk/mortality. He is MPI on the ColoCare Study (U01CA206110), a large multicenter cohort of colorectal cancer (CRC) patients for interdisciplinary studies of CRC prognosis and outcomes.
660 S. Euclid Avenue
Campus Box 8100
St. Louis, MO 63110